Terms: = Colorectal cancer AND KIT, C-Kit, 3815, ENSG00000157404, CD117, SCFR, P10721 AND Prognosis
213 results:
1. Overexpression of ZNF169 promotes the growth and proliferation of colorectal cancer cells via the upregulation of ANKZF1.
Zhang J; Wang Y; Hou S; Chi X; Ding D; Xue M; Zhang M; Wang J; Shuai J; Sun H; Gao Q; Kang C
Oncol Rep; 2024 Jun; 51(6):. PubMed ID: 38666541
[TBL] [Abstract] [Full Text] [Related]
2. Regorafenib and glioblastoma: a literature review of preclinical studies, molecular mechanisms and clinical effectiveness.
Mongiardi MP; Pallini R; D'Alessandris QG; Levi A; Falchetti ML
Expert Rev Mol Med; 2024 Apr; 26():e5. PubMed ID: 38563164
[TBL] [Abstract] [Full Text] [Related]
3. Effect of Cichoric Acid on colorectal cancer: Impact on Migration, Epithelial-Mesenchymal Transition, and Proliferation
Ma S; Huang Z; Chen Q; Yin X
Discov Med; 2024 Jan; 36(180):190-198. PubMed ID: 38273759
[TBL] [Abstract] [Full Text] [Related]
4. MiR-214-3p overexpression-triggered chondroitin polymerizing factor (CHPF) inhibition modulates the ferroptosis and metabolism in colon cancer.
Yun ZY; Wu D; Wang X; Huang P; Li N
Kaohsiung J Med Sci; 2024 Mar; 40(3):244-254. PubMed ID: 38190270
[TBL] [Abstract] [Full Text] [Related]
5. Site specific genetic differences in colorectal cancer via Next-Generation-Sequencing using a multigene panel.
Rencuzogullari A; Bisgin A; Erdogan KE; Gumus S; Yalav O; Boga I; Sonmezler O; Eray IC
Ann Ital Chir; 2023; 94():605-611. PubMed ID: 38131395
[TBL] [Abstract] [Full Text] [Related]
6. Deoxyribonuclease 1-like 3 inhibits colorectal malignancy through antagonizing NEDD4-triggered CDKN1A ubiquitination.
Yu L; Huang J
Cell Biol Int; 2024 Mar; 48(3):325-333. PubMed ID: 38108119
[TBL] [Abstract] [Full Text] [Related]
7. SNORA56-mediated pseudouridylation of 28 S rRNA inhibits ferroptosis and promotes colorectal cancer proliferation by enhancing GCLC translation.
Xu C; Bian Z; Wang X; Niu N; Liu L; Xiao Y; Zhu J; Huang N; Zhang Y; Chen Y; Wu Q; Sun F; Zhu X; Pan Q
J Exp Clin Cancer Res; 2023 Dec; 42(1):331. PubMed ID: 38049865
[TBL] [Abstract] [Full Text] [Related]
8. Mechanistic study on ursolic acid inhibiting the growth of colorectal cancer cells through the downregulation of TGF-β3 by miR-140-5p.
Zhang T; Xiang F; Li X; Chen Z; Wang J; Guo J; Zhu S; Zhou J; Kang X; Wu R
J Biochem Mol Toxicol; 2024 Jan; 38(1):e23581. PubMed ID: 38044485
[TBL] [Abstract] [Full Text] [Related]
9. Development of a 5-mRNAsi-related gene signature to predict the prognosis of colon adenocarcinoma.
Huang H; Lu L; Li Y; Chen X; Li M; Yang M; Huang X
PeerJ; 2023; 11():e16477. PubMed ID: 38025763
[TBL] [Abstract] [Full Text] [Related]
10. Evaluation of cell surface vimentin positive circulating tumor cells as a prognostic biomarker for stage III/IV colorectal cancer.
Yu J; Yang M; Peng T; Liu Y; Cao Y
Sci Rep; 2023 Nov; 13(1):18791. PubMed ID: 37914786
[TBL] [Abstract] [Full Text] [Related]
11. Knockdown of Long Noncoding RNA CCAT2 Suppresses Malignant Phenotype in Human Laryngeal Squamous Cell Carcinoma.
Li M; An J; Ren H; Gui J; Wang H; Wu S; Wu R; Xiao H; Wang L
Bull Exp Biol Med; 2023 Sep; 175(5):673-680. PubMed ID: 37874495
[TBL] [Abstract] [Full Text] [Related]
12. TRIM29 promotes the progression of colorectal cancer by suppressing EZH2 degradation.
Chen Y; Ma J; Zhang M
Exp Biol Med (Maywood); 2023 Sep; 248(18):1527-1536. PubMed ID: 37837384
[TBL] [Abstract] [Full Text] [Related]
13. Whole-exome sequencing reveals mutational profiles of anorectal and gynecological melanoma.
Sun W; Liu K; Zhou H; Zhao F; Dong Y; Xu Y; Kong Y; Wang M; Cheng X; Chen Y
Med Oncol; 2023 Oct; 40(11):330. PubMed ID: 37831226
[TBL] [Abstract] [Full Text] [Related]
14. METTL3/IGF2BP2 axis affects the progression of colorectal cancer by regulating m6A modification of STAG3.
Yi J; Peng F; Zhao J; Gong X
Sci Rep; 2023 Oct; 13(1):17292. PubMed ID: 37828232
[TBL] [Abstract] [Full Text] [Related]
15. Crocin exerts anti-tumor effect in colon cancer cells via repressing the JAK pathway.
Yang H; Zhang Y; Zhang D; Qian L; Yang T; Wu X
Eur J Histochem; 2023 Sep; 67(3):. PubMed ID: 37700733
[TBL] [Abstract] [Full Text] [Related]
16. CircAGFG1 absence decreases PKM2 expression to enhance oxaliplatin sensitivity in colorectal cancer in a miR-7-5p-dependent manner.
Chen J; Wang H; Tang M
J Chemother; 2024 May; 36(3):208-221. PubMed ID: 37691430
[TBL] [Abstract] [Full Text] [Related]
17. Knockdown of Secernin 1 inhibit cell invasion and migration by activating the TGF-β/Smad3 pathway in oral squamous cell carcinomas.
Xiao L; Zhang T; Zheng K; Xiao Q; Zhang W; Zhang D; Wu D; He C; Zhou Y; Liu Y
Sci Rep; 2023 Sep; 13(1):14922. PubMed ID: 37691034
[TBL] [Abstract] [Full Text] [Related]
18. GPX2 acts as an oncogene and cudraflavone C has an anti-tumor effect by suppressing GPX2-dependent Wnt/β-catenin pathway in colorectal cancer cells.
Wu Z; Zhou S; Liang D; Mu L
Naunyn Schmiedebergs Arch Pharmacol; 2024 Feb; 397(2):1115-1125. PubMed ID: 37610461
[TBL] [Abstract] [Full Text] [Related]
19. TRIM58 functions as a tumor suppressor in colorectal cancer by promoting RECQL4 ubiquitination to inhibit the AKT signaling pathway.
Sun N; Shen J; Shi Y; Liu B; Gao S; Chen Y; Sun J
World J Surg Oncol; 2023 Jul; 21(1):231. PubMed ID: 37516854
[TBL] [Abstract] [Full Text] [Related]
20. Mast cells in colorectal cancer tumour progression, angiogenesis, and lymphangiogenesis.
Liu X; Li X; Wei H; Liu Y; Li N
Front Immunol; 2023; 14():1209056. PubMed ID: 37497234
[TBL] [Abstract] [Full Text] [Related]
[Next]
